Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02127710
Title A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR | ESP | CAN

Facility Status City State Zip Country Details
Research Site Birmingham Alabama 35294 United States Details
Research Site Duarte California 91010 United States Details
Research Site Palo Alto California 94305 United States Details
Research Site Fort Myers Florida 33916 United States Details
Research Site Chicago Illinois 60637 United States Details
Research Site Iowa City Iowa 52242 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site New York New York 10021 United States Details
Research Site Philadelphia Pennsylvania 19111 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Dallas Texas 75246 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Calgary Alberta T2N 4N2 Canada Details
Research Site Edmonton Alberta T6G 1Z2 Canada Details
Research Site Toronto Ontario M4N 3M5 Canada Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Barcelona 08041 Spain Details
Research Site Cambridge CB2 0QQ United Kingdom Details
Research Site Glasgow G12 OYN United Kingdom Details
Research Site London EC1M 6BQ United Kingdom Details
Research Site London W1G 6AD United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field